Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

about

Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology.Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.

P2860

Q48091597-4A6EBC23-B4D4-4888-855A-C6DC0363EA6A Q55360759-2AE41775-8BDA-4955-A983-AF5EC93D5271

P2860

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

Item

http://www.wikidata.org/entity/Q40483682

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Unravelling the relevance of C ...... r in myelodysplastic syndrome.

@en

type

Item

label

Unravelling the relevance of C ...... r in myelodysplastic syndrome.

@en

prefLabel

Unravelling the relevance of C ...... r in myelodysplastic syndrome.

@en

P1476

Unravelling the relevance of C ...... r in myelodysplastic syndrome.

@en

P2093

Anne Stidsholt Roug

http://www.w3.org/2001/XMLSchema#string

Eigil Kjeldsen

http://www.w3.org/2001/XMLSchema#string

Gitte B Kerndrup

http://www.w3.org/2001/XMLSchema#string

Gordon D Brown

http://www.w3.org/2001/XMLSchema#string

Line Nederby

http://www.w3.org/2001/XMLSchema#string

P2860

Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research

Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy

Proposals for the classification of the myelodysplastic syndromes

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.

Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation.

Revised international prognostic scoring system for myelodysplastic syndromes.

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.

P304

393-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14270

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P50

Peter Hokland

Marie Toft-Petersen

P577

2016-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27612176

http://www.w3.org/2001/XMLSchema#string

P932

5091626

http://www.w3.org/2001/XMLSchema#string

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

about

P2860

P2860

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932